Lu Lin

Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial

Wen Guo, Wenjun Tian, Lu Lin et al. · Diabetes Research and Clinical Practice · 2020 · 109 citations

Obesity, Metabolic Syndrome, Nutrition +12

Treatment with liraglutide, a glucagon-like peptide-1 analogue, improves effectively the skin lesions of psoriasis patients with type 2 diabetes: A prospective cohort study

Xiangjin Xu, Lu Lin, Pin Chen et al. · Diabetes Research and Clinical Practice · 2019 · 59 citations

Inflammation, Psoriasis Patients, Medicine +7

Glucagon-like peptide-1 receptor agonist liraglutide therapy for psoriasis patients with type 2 diabetes: a randomized-controlled trial

Lu Lin, Xiangjin Xu, Yu Yunjie et al. · Journal of Dermatological Treatment · 2020 · 58 citations

Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats

Xiangjin Xu, Wenqing Wang, Lu Lin et al. · Tissue and Cell · 2020 · 48 citations

Inflammation, T2dm/nafld Rats, Liver Lesions +12

RETRACTED: Exosomal miR-22-3p from human umbilical cord blood-derived mesenchymal stem cells protects against lipopolysaccharid-induced acute lung injury

Yuanfang Zheng, Jiyuan Liu, Ping Chen et al. · Life Sciences · 2021 · 35 citations

Acute Lung Injury, Extracellular Vesicles, Regenerative Medicine +10